DPIIT recognised startup Government of India
Startup India
Procell Biologics Private Limited - pharma in Medchal, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14,740
▼ 99% YoY
Net loss · FY 2025
₹13.01 Cr
Latest filing
EBITDA · FY 2025
-₹10.65 Cr
Latest filing
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹10.37 Cr
Issued & subscribed
Open charges
₹30 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
52
Provident fund records
About Procell Biologics Private Limited
Data last updated:
Procell Biologics Private Limited is a private limited company based in Medchal, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC150610. Its GSTIN is 36AALCP9371R1ZA (Telangana).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹10.37 Cr. It is led by directors including Srinivasa Chowdary Akkina and Srinivas Suveerji Cherukuri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Building No189 2nd Floor Mn Park Synergy Square 1 Genome Valley Turkapally(V) Shamirpet(M), Medchal, Telangana, India – 500078.
As per the financials filed for FY 2025, the company reported a revenue of ₹14,740, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹13.01 Cr and EBITDA of -₹10.65 Cr.
The company has about 52 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Procell Biologics. As per MCA filings, the company has open charges of ₹30 Lakh on record.
For more details, the company can be reached via its website procellbiologics.com.
Company details
CIN U24290TG2021PTC150610
Registration Number 150610
Incorporation Date 14 April 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
Key People
Srinivasa Chowdary Akkina Director Srinivas Suveerji Cherukuri Director Muni Koteswara Rao Akkina Director Recognitions & Rankings of Procell Biologics
Contact details
Procell Biologics Private Limited's registered office is in Medchal, Telangana. Its website is procellbiologics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBuilding No189 2nd Floor Mn Park Synergy Square 1 Genome Valley Turkapally(V) Shamirpet(M), Medchal, Telangana, India – 500078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Procell Biologics Private Limited, buy the company report.
Comprehensive company report
Procell Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Procell Biologics operates one associated brand: Procell Biologics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops biosimilars for metabolic disorders, inflammatory diseases, and cancer treatments. | procellbiologics.com |
Financials of Procell Biologics Private Limited
FY 2024 filings availableProcell Biologics Private Limited reported revenue of ₹14,740 (down 99% YoY) for FY 2025.
Revenue · FY 2025
₹14,740 ▼ 99%
Net loss · FY 2025
₹13.01 Cr
EBITDA · FY 2025
-₹10.65 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 99%
EBITDA CAGR growth
1 year
▼ 59%
3 years · compounded
▼ 71%
Revenue fell 99% in the latest year. EBITDA fell 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹10.65 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹13.01 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Procell Biologics Private Limited, buy the company report.
Board of directors of Procell Biologics Private Limited
Procell Biologics has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Chowdary Akkina Also directs: Lakshmibalaji Infratech LLP, Svenra Asset Management LLP, Akkina Asset Management LLP and 5 more | Director | 14 Apr 2021 | 5 Years 6 Months | Current |
| Srinivas Suveerji Cherukuri Also directs: Cherukuri Veerraju Industries Private Limited, Lextro Labs Private Limited, Lextro Bio Solutions Private Limited and 3 more | Director | 14 Apr 2021 | 5 Years 6 Months | Current |
| Muni Koteswara Rao Akkina Also directs: Lakshmisrinivasa Minerals LLP, Lakshmisrinivasa Buildcon LLP, Lakshmibalaji Infratech LLP and 5 more | Director | 14 Apr 2021 | 5 Years 6 Months | Current |
| Surya Prabhavathi Akkina Also directs: Ch.Veerraju Mines & Minerals Private Limited | Director | 14 Apr 2021 | 5 Years 6 Months | Current |
| Venkata Krishnaji Cherukuri Also directs: Ch.Veerraju Mines & Minerals Private Limited, Cherukuri Veerraju Industries Private Limited, Lextro Labs Private Limited and 5 more | Director | 14 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Procell Biologics Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biologics, Biotechnology), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Moredx Biologics Private Limited | ₹19,734 (FY 2025) | Delhi, India | ||||
| Greyfast Technology Private Limited | ₹19,620 (FY 2025) | -24.0% | Navi Mumbai, Maharashtra, India | |||
| Amthera Life Sciences Private Limited | ₹18,360 (FY 2025) | -23.0% | Bangalore, Second Floor, Karnataka, India | |||
| Avestagenome Project International Private Limited | ₹16,997 (FY 2022) | Bgnorth, Karnataka, India | ||||
| Parth Biocare Private Limited | ₹16,690 (FY 2025) | 7.0% | Bhilai, Chhattisgarh, India | |||
| Procell Biologics Private Limitedthis company | ₹14,740 (FY 2025) | -₹13.01 Cr | -99.0% | 52 | Medchal, Telangana, India | |
| Council for Healthcare and Pharma Front | ₹13,829 (FY 2025) | 400.0% | New Delhi, Delhi, India | |||
| Kis Technologies (India) Private Limited | ₹13,544 (FY 2018) | Bangalore, Karnataka, India | ||||
| Mercuri Biotechnologies Private Limited | ₹13,125 (FY 2021) | -99.0% | Bangalore, Karnataka, India | |||
| Extremz Biosciences Private Limited | ₹13,049 (FY 2022) | -95.0% | Hubli, Karnataka, India | |||
| Navya Life Sciences Research Foundation | ₹12,968 (FY 2025) | -18.0% | Hubli, Karnataka, India |
To see the full peer comparison of Procell Biologics Private Limited, buy the company report.
Auditor
Procell Biologics Private Limited is audited by BHARATAM BRAHMANANDA RAO AND CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHARATAM BRAHMANANDA RAO AND CO | FY 2024 | 017369S |
Shareholding
The shareholding of Procell Biologics Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Procell Biologics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Oct 2023 | 100827661 | Hdfc Bank Limited | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Procell Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Procell Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Procell Biologics Private Limited has a workforce of 52 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.
Employee count
52
Active EPFO establishments
1
Employee growth
33.33%
GST
Procell Biologics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AALCP9371R1ZA | Telangana | Active | 10 May 2021 |
To see the full GST registrations and return filing status of Procell Biologics Private Limited, buy the company report.
Recent activity
Procell Biologics Private Limited has 5 board changes on record since 2021: 5 appointments. The latest: Muni Koteswara Rao Akkina was appointed as Director on 14 Apr 2021.
AGM
Procell Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Procell Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100827661 was registered on 27 Oct 2023.
Appointed
Muni Koteswara Rao Akkina was appointed as Director.
Appointed
Srinivas Suveerji Cherukuri was appointed as Director.
Appointed
Srinivasa Chowdary Akkina was appointed as Director.
Appointed
Surya Prabhavathi Akkina was appointed as Director.
Appointed
Venkata Krishnaji Cherukuri was appointed as Director.
Incorporation
14 Apr 2021
Procell Biologics Private Limited was registered on 14 Apr 2021 with Roc Hyderabad & aged 5 years 6 months as per MCA records.
Frequently asked questions
Procell Biologics is an active private limited company based in Medchal, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 April 2021 (5+ years old) and is registered under CIN U24290TG2021PTC150610.
Procell Biologics has 5 current directors:
- Srinivasa Chowdary Akkina - Director
- Srinivas Suveerji Cherukuri - Director
- Muni Koteswara Rao Akkina - Director
- Surya Prabhavathi Akkina - Director
- Venkata Krishnaji Cherukuri - Director
The latest financial statements of Procell Biologics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Procell Biologics is 36AALCP9371R1ZA, registered in Telangana.
The CIN (Corporate Identification Number) of Procell Biologics is U24290TG2021PTC150610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Procell Biologics was incorporated on 14 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Procell Biologics by revenue are Moredx Biologics Private Limited, Greyfast Technology Private Limited, Amthera Life Sciences Private Limited, Avestagenome Project International Private Limited, Parth Biocare Private Limited and 5 more, all in the Biotechnology industry (Biologics, Biotechnology).
Muni Koteswara Rao Akkina was appointed as Director on 14 Apr 2021. Srinivas Suveerji Cherukuri was appointed as Director on 14 Apr 2021. Srinivasa Chowdary Akkina was appointed as Director on 14 Apr 2021. Procell Biologics has 5 board changes on record in total.
Yes, Procell Biologics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Procell Biologics can be reached through the website procellbiologics.com. Its registered office is in Medchal, Telangana, India.
The registered office of Procell Biologics is at Building No189 2nd Floor Mn Park Synergy Square 1 Genome Valley TurkapallyV ShamirpetM, Medchal, Telangana, India – 500078.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages